Eric Jermyn, a licensed insurance broker and consultant with Bangor-based Cross Insurance, estimates that fewer than 10% of the thousands of employers he works with cover GLP-1s for weight loss, though many more cover it for certain conditions like diabetes
Jauhari A, Singh T, Mishra S et al (2020) Coordinated action of miR-146a and parkin gene regulate rotenone-induced neurodegeneration
Postow MA, Sidlow R, Hellmann MD (2018) Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
C Final Thoughts The Zepbound vial is an effective option for individuals serious about weight management with GLP-1 therapy
More than 15 new obesity medications are expected to gain approval over the next five years
However, glycine does not directly address B12 deficiency, which is a real risk during prolonged GLP-1 therapy